[en] BACKGROUND: Overall rates of bloodstream infection (BSI) are often used as quality indicators in intensive care units (ICUs). We investigated whether ICU-acquired BSI increased mortality (by > or = 10%) after adjustment for severity of infection at ICU admission and during the pre-BSI stay. METHODS: We conducted a matched, risk-adjusted (1:n), exposed-unexposed study of patients with stays longer than 72 h in 12 ICUs randomly selected from the Outcomerea database. RESULTS: Patients with BSI after the third ICU day (exposed group) were matched on the basis of risk-exposure time and mortality predicted at admission using the Three-Day Recalibrated ICU Outcome (TRIO) score to patients without BSI (unexposed group). Severity was assessed daily using the Logistic Organ Dysfunction (LOD) score. Of 3247 patients with ICU stays of >3 days, 232 experienced BSI by day 30 (incidence, 6.8 cases per 100 admissions); among them, 226 patients were matched to 1023 unexposed patients. Crude hospital mortality was 61.5% among exposed and 36.7% among unexposed patients (P<.0001). Attributable mortality was 24.8%. The only variable associated with both BSI and hospital mortality was the LOD score determined 4 days before onset of BSI (odds ratio [OR], 1.10; 95% confidence interval [CI], 1.03-1.16; P = .0025). The adjusted OR for hospital mortality among exposed patients (OR, 3.20; 95% CI, 2.30-4.43) decreased when the LOD score determined 4 days before onset of BSI was taken into account (OR, 3.02; 95% CI, 2.17-4.22; P<.0001). The estimated risk of death from BSI varied considerably according to the source and resistance of organisms, time to onset, and appropriateness of treatment. CONCLUSIONS: When adjusted for risk-exposure time and severity at admission and during the ICU stay, BSI was associated with a 3-fold increase in mortality, but considerable variation occurred across BSI subgroups. Focusing on BSI subgroups may be valuable for assessing quality of care in ICUs.
Disciplines :
Anesthesia & intensive care
Author, co-author :
Garrouste-Orgeas, Maite
Timsit, Jean Francois
Tafflet, Muriel
Misset, Benoît ; Centre Hospitalier Universitaire de Liège - CHU > Service de Soins Intensifs
Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-601.
Renaud B, Brun-Buisson C. Outcomes of primary and catheter-related bacteremia. Am J Respir Crit Care Med 2001; 163:1584-90.
Blot S, Vanderwoude K, Hoste E, et al. Absence of excess mortality in critically ill patients with nosocomial Escherichia coli bacteremia. Infect Control Hosp Epidemiol 2003; 24:912-5.
Blot S, Vanderwoude K, Colardyn F. Evaluation of outcome in critically ill patients with nosocomial Enterobacter bacteremia: results of a matched cohort study. Chest 2003; 123:1208-13.
Blot S, Vanderwoude K, Colardyn F. Clinical impact of nosocomial Klebsiella bacteremia in critically ill patients. Eur J Clin Microbiol Infect Dis 2002; 21:471-3.
Blot S, Vanderwoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Medicine 2003; 29:471-5.
Blot S, Vanderwoude K, Hoste E, Colardyn F. Reappraisal of attributable mortality in critically ill patients with nosocomial bacteremia involving Pseudomonas aeruginosa. J Hosp Infect 2003; 53:18-24.
Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160:976-81.
Le Gall JR, Lesmeshow S, Saulnier F. A new simplified Acute Physiologic Score (SAPS II) based on Europe and North American multicenter study. JAMA 1993; 270:2957-63.
Lemeshow S, Klar J, Terres D, et al. Mortality probability models for patients in the intensive care unit for 48 or 72 hours: a prospective multicenter study. Crit Care Med 1994; 22:1351-8.
Wagner DP, Knaus WA, Harrel FE, Zimmerman JE, Watts C. Daily prognostic estimates for critically ill adults in intensive care units: results from a prospective, multicenter, inception cohort analysis. Crit Care Med 1994; 22:1359-72.
Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Result of a prospective multicenter study. Intensive Care Med 1999; 25:686-96.
Godhill DR, Summer A. Outcome of intensive care patients in a group of British intensive care units. Crit Care Med 1998; 26:1337-45.
Suistomaa M, Kari A, Ruokonen E, Takala J. Sampling rates causes bias in Apache II and SAPS II scores. Intensive Care Med 2000; 26:1773-8.
Timsit JF, Fosse JP, Troche G, et al. Calibration and discrimination by daily logistic organ dysfunction scoring comparatively with daily sequential organ failure assessment scoring for predicting hospital mortality in critically ill patients. Crit Care Med 2002; 30:2003-13.
Timsit JF, Fosse JP, Troche G, et al. Accuracy of a composite score using daily SAPS II and LOD scores for predicting hospital mortality in ICU patients hospitalized for more than 72 hours. Intensive Care Med 2001; 27:1012-21.
Rue M, Quintana S, Alvarez M, Artigas A. Daily assessment of severity of illness and mortality prediction for individual patients. Crit Care Med 2001; 29:45-50.
Chevret S, Timsit JF. Attributable mortality an open issue. Am J Respir Crit Care Med 1999; 159:341-2.
Clec'h C, Timsit JF, De Lassence A, et al. Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia; influence of disease severity. Intensive Care Med 2004; 30:1327-33.
Girou E, Stephan F, Novara A, Safar M, Fagon Y. Risk factors and outcome of nosocomial infections: results of a matched case-control study of ICU patients. Am J Respir Crit Car Med 1998; 157:1151-8.
Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol 1999; 20:396-401.
Rello J, Jubert P, Valles J, Artigas A, Rue M, Niederman MS. Evaluation of outcome for intubated patients with pneumonia due to Pseudomonas aeruginosa. Clin Infect Dis 1996; 23:973-8.
Yzerman EP, Boelens HA, Tjhie JH, Kluytmans JA, Mouton JW, Verbrugh HA. Delta Apache II score for predicting course and outcome of nosocomial Staphylococcus aureus bacteremia and its relation to host defense. J Infect Dis 1996; 173:914-9.
McCabe WR, Jackson GG. Gram negative bacteremia: etiology and ecology. Arch Intern Med 1962; 110:847-55.
Knaus WA, Drapper EA, Wagner D, Zimmerman JE. Apache II: a severity of disease classification. Crit Care Med 1985; 13:818-29.
Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A. The logistic organ dysfunction system: a new way to assess organ dysfunction in the intensive care unit. ICU scoring group. JAMA 1996; 276:802-10.
Martin MA, Pfaller MA, Wenzel. Coagulase-negative staphylococcal bacteremia. Mortality and hospital stay. Ann Intern Med 1989; 110:9-16.
Roberts FJ. Definition of polymicrobial bacteremia. Rev Infect Dis 1989; 11:1029-30.
Brun-Buisson C, Abroug F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnostic of central venous catheter-related infection: critical level of quantitative tip cultures. Arch Intern Med 1987; 147:873-7.
Casagrande JT, Pike MC. An improved approximate formula for calculating sample sizes for comparing two binomial distributions. Biometrics 1978; 34:483-6.
OUTCOMEREA. Finding matched controls for a case control study using your own criteria: SAS macro programming. Available at: http: //www.outcomerea.org/ ehtm/matchmacro.pdf. Accessed 16 February 2006.
Alberti C, Metivier F, Landais P, et al. Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. J Clin Epidemiol 2003; 56:536-45.
Rello J, Ricart M, Mirelis B, et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med 1994; 20:94-8.
Pittet D, Thievent B, Wenzel RP, Li N, Auckenthaller R, Suter PM. Bedside prediction of mortality from bacteremic sepsis: a dynamic analysis of ICU patients. Am J Respir Crit Care Med 1996; 153:684-93.
Garrouste-Orgeas M, Chevret S, Mainardi JL, Timsit JF, Misset B, Carlet J. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on outcome. J Hosp Infection 2000; 44:206-13.
Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. Am J Respir Crit Care Med 1996; 154:617-24.
Hugonnet S, Harbarth S, Ferriere K, Ricou B, Suter P, Pittet D. Bacteremic sepsis in intensive care: temporal trends in incidence organ dysfunction and prognosis. Crit Care Med 2003; 31:390-4.
Hervaldt LA, Geiss M, Kao C, Pfaller MA. The positive predicting value of isolating Coagulase-negative staphylococci from blood cultures. Clin Infect Dis 1996; 22:14-20.
Warren DK, Zack JE, Elward AE, Cox MJ, Fraser VJ. Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: a 21-month prospective study. Clin Infect Dis 2001; 33:1329-35.
Sicignano A, Carozzi C, Giudici D, Merli G, Arlati S, Pulici M. The influence of length of stay in the ICU on power of discrimination of multipurpose severity score (SAPS). Archidia. Intensive Care Med 1996; 22:1048-51.
Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754-8.
Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162:2229-2235.
Alberti C, Brun-Buisson C, Goodman SV, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003; 168:77-84.
Ely EW, Laterre PF, Angus DC, et al. Dotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis. Crit Care Med 2003; 31:12-9.
